These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23400748)

  • 21. A prospective pharmacovigilance study in the infectious diseases unit of a tertiary care hospital.
    Karaismailoglu B; Saltoglu N; Balkan II; Mete B; Tabak F; Ozturk R
    J Infect Dev Ctries; 2019 Jul; 13(7):649-655. PubMed ID: 32065823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacovigilance in children in Camagüey Province, Cuba.
    Bárzaga Arencibia Z; López Leyva A; Mejías Peña Y; González Reyes AR; Fernández Manzano E; Choonara I
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1079-84. PubMed ID: 22315149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan Adverse Drug Events Study.
    Murayama H; Sakuma M; Takahashi Y; Morimoto T
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital.
    Murali M; Suppes SL; Feldman K; Goldman JL
    PLoS One; 2021; 16(1):e0245368. PubMed ID: 33439905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].
    Olivier P; Caron J; Haramburu F; Imbs JL; Jonville-Béra AP; Lagier G; Sgro C; Vial T; Montastruc JL; Lapeyr-Mestre M
    Therapie; 2005; 60(1):39-45. PubMed ID: 15929472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions in neonates: a prospective study.
    Belén Rivas A; Arruza L; Pacheco E; Portoles A; Diz J; Vargas E
    Arch Dis Child; 2016 Apr; 101(4):371-6. PubMed ID: 26819267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of adverse drug reactions causing admission to an intensive care unit.
    Rojas-Velandia C; Ruiz-Garzón J; Moscoso-Alcina JC; Vallejos-Narvaéz Á; Castro-Canoa J; Bustos-Martínez Y; Flórez-Cutiva M; Contreras-Muñoz M; Gómez-Gil JC; Calderón-Ospina CA
    Br J Clin Pharmacol; 2017 May; 83(5):1134-1140. PubMed ID: 27905143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the Risk of Adverse Drug Reactions in Older Inpatients: External Validation of the GerontoNet ADR Risk Score Using the CRIME Cohort.
    Petrovic M; Tangiisuran B; Rajkumar C; van der Cammen T; Onder G
    Drugs Aging; 2017 Feb; 34(2):135-142. PubMed ID: 28000156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive monitoring of adverse drug reactions in nephrology unit of tertiary care teaching hospital.
    Kareem SA; Sridhar SB; Shetty MS
    Saudi J Kidney Dis Transpl; 2019; 30(5):1075-1083. PubMed ID: 31696846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions in a paediatric intensive care unit.
    Gill AM; Leach HJ; Hughes J; Barker C; Nunn AJ; Choonara I
    Acta Paediatr; 1995 Apr; 84(4):438-41. PubMed ID: 7795356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.
    Franceschi M; Scarcelli C; Niro V; Seripa D; Pazienza AM; Pepe G; Colusso AM; Pacilli L; Pilotto A
    Drug Saf; 2008; 31(6):545-56. PubMed ID: 18484788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
    Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
    Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.
    Fracchiolla NS; Artuso S; Cortelezzi A; Pelizzari AM; Tozzi P; Bonfichi M; Bocchio F; Gargantini L; De Rosa E; Vighi GD; Prestini L; Sammassimo S; Frungillo N; Pasquini MC; Ragazzi A; Boghi D; Pastore A; Lanzi E; Gritti G; Quaresmini G; Voltolini S; Gaiardoni R; Corti C; Vilardo MC; La Targia ML; Berini G; Magagnoli M; Bacci C; Consonni D; Rivolta AL; Muti G
    Hematol Oncol; 2018 Feb; 36(1):299-306. PubMed ID: 28771763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.